scholarly journals Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

2018 ◽  
Vol 254 ◽  
pp. 125-131 ◽  
Author(s):  
María Asunción Esteve-Pastor ◽  
José Miguel Rivera-Caravaca ◽  
Vanessa Roldán ◽  
Vicente Vicente ◽  
Giulio Francesco Romiti ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Real World ◽  
Oral Anticoagulants ◽  
Vitamin K Antagonist ◽  
Efficacy And Safety ◽  
Safety Outcomes ◽  
Anticoagulated Patients

scholarly journals Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer in Real World: Meta-Analysis of Retrospective Observational Studies

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Cao B ◽  
Hu X ◽  
Chen M ◽  
Shen M ◽  
Xu L
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Real World ◽  
Observational Studies ◽  
Meta Analysis ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Vitamin K Antagonist ◽  
Efficacy And Safety ◽  
Patients With Cancer

Background: Evidence on the safety and effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation (AF) patients with cancer is rather limited, so we performed this meta-analysis to compare the efficacy and safety of NOACs with vitamin K antagonists (VKAs) in real-world patients with AF and cancer.

scholarly journals Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation

2015 ◽  
Vol 79 (2) ◽  
pp. 339-345 ◽  
Author(s):  
Keitaro Senoo ◽  
Yee Cheng Lau ◽  
Mikhail Dzeshka ◽  
Deirdre Lane ◽  
Ken Okumura ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Japanese Patients ◽  
Vitamin K Antagonist ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document